Cargando…

The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial

SIMPLE SUMMARY: There is no clear evidence on the most effective method of pathological analysis and clearance definition (0 vs. 1 mm) to define R1 resection after pancreatoduodenectomy (PD). However, several studies showed that the R1 resection is a poor prognostic factor in patients that have unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Nappo, Gennaro, Borzomati, Domenico, Zerbi, Alessandro, Spaggiari, Paola, Boggi, Ugo, Campani, Daniela, Mrowiec, Sławomir, Liszka, Łukasz, Coppola, Alessandro, Amato, Michela, Petitti, Tommasangelo, Vistoli, Fabio, Montorsi, Marco, Perrone, Giuseppe, Coppola, Roberto, Caputo, Damiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123600/
https://www.ncbi.nlm.nih.gov/pubmed/33926138
http://dx.doi.org/10.3390/cancers13092097
_version_ 1783692955157004288
author Nappo, Gennaro
Borzomati, Domenico
Zerbi, Alessandro
Spaggiari, Paola
Boggi, Ugo
Campani, Daniela
Mrowiec, Sławomir
Liszka, Łukasz
Coppola, Alessandro
Amato, Michela
Petitti, Tommasangelo
Vistoli, Fabio
Montorsi, Marco
Perrone, Giuseppe
Coppola, Roberto
Caputo, Damiano
author_facet Nappo, Gennaro
Borzomati, Domenico
Zerbi, Alessandro
Spaggiari, Paola
Boggi, Ugo
Campani, Daniela
Mrowiec, Sławomir
Liszka, Łukasz
Coppola, Alessandro
Amato, Michela
Petitti, Tommasangelo
Vistoli, Fabio
Montorsi, Marco
Perrone, Giuseppe
Coppola, Roberto
Caputo, Damiano
author_sort Nappo, Gennaro
collection PubMed
description SIMPLE SUMMARY: There is no clear evidence on the most effective method of pathological analysis and clearance definition (0 vs. 1 mm) to define R1 resection after pancreatoduodenectomy (PD). However, several studies showed that the R1 resection is a poor prognostic factor in patients that have undergone PDs for periampullary cancers. In this randomized clinical trial, specimens were randomized with two pathological methods, the Leeds Pathology Protocol (LEEPP) or the conventional method adopted before the study. The 1 mm clearance is the most effective factor in determining R1 rate after PD but only when adopting the LEEP, the R1 resection represents a significant prognostic factor. ABSTRACT: Background: There is extreme heterogeneity in the available literature on the determination of R1 resection rate after pancreatoduodenectomy (PD); consequently, its prognostic role is still debated. The aims of this multicenter randomized study were to evaluate the effect of sampling and clearance definition in determining R1 rate after PD for periampullary cancer and to assess the prognostic role of R1 resection. Methods: PD specimens were randomized to Leeds Pathology Protocol (LEEPP) (group A) or the conventional method adopted before the study (group B). R1 rate was determined by adopting 0- and 1-mm clearance; the association between R1, local recurrence (LR) and overall survival (OS) was also evaluated. Results. One-hundred-sixty-eight PD specimens were included. With 0 mm clearance, R1 rate was 26.2% and 20.2% for groups A and B, respectively; with 1 mm, R1 rate was 60.7% and 57.1%, respectively (p > 0.05). Only in group A was R1 found to be a significant prognostic factor: at 0 mm, median OS was 36 and 20 months for R0 and R1, respectively, while at 1 mm, median OS was not reached and 30 months. At multivariate analysis, R1 resection was found to be a significant prognostic factor independent of clearance definition only in the case of the adoption of LEEPP. Conclusions. The 1 mm clearance is the most effective factor in determining the R1 rate after PD. However, the pathological method is crucial to accurately evaluate its prognostic role: only R1 resections obtained with the adoption of LEEPP seem to significantly affect prognosis.
format Online
Article
Text
id pubmed-8123600
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81236002021-05-16 The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial Nappo, Gennaro Borzomati, Domenico Zerbi, Alessandro Spaggiari, Paola Boggi, Ugo Campani, Daniela Mrowiec, Sławomir Liszka, Łukasz Coppola, Alessandro Amato, Michela Petitti, Tommasangelo Vistoli, Fabio Montorsi, Marco Perrone, Giuseppe Coppola, Roberto Caputo, Damiano Cancers (Basel) Article SIMPLE SUMMARY: There is no clear evidence on the most effective method of pathological analysis and clearance definition (0 vs. 1 mm) to define R1 resection after pancreatoduodenectomy (PD). However, several studies showed that the R1 resection is a poor prognostic factor in patients that have undergone PDs for periampullary cancers. In this randomized clinical trial, specimens were randomized with two pathological methods, the Leeds Pathology Protocol (LEEPP) or the conventional method adopted before the study. The 1 mm clearance is the most effective factor in determining R1 rate after PD but only when adopting the LEEP, the R1 resection represents a significant prognostic factor. ABSTRACT: Background: There is extreme heterogeneity in the available literature on the determination of R1 resection rate after pancreatoduodenectomy (PD); consequently, its prognostic role is still debated. The aims of this multicenter randomized study were to evaluate the effect of sampling and clearance definition in determining R1 rate after PD for periampullary cancer and to assess the prognostic role of R1 resection. Methods: PD specimens were randomized to Leeds Pathology Protocol (LEEPP) (group A) or the conventional method adopted before the study (group B). R1 rate was determined by adopting 0- and 1-mm clearance; the association between R1, local recurrence (LR) and overall survival (OS) was also evaluated. Results. One-hundred-sixty-eight PD specimens were included. With 0 mm clearance, R1 rate was 26.2% and 20.2% for groups A and B, respectively; with 1 mm, R1 rate was 60.7% and 57.1%, respectively (p > 0.05). Only in group A was R1 found to be a significant prognostic factor: at 0 mm, median OS was 36 and 20 months for R0 and R1, respectively, while at 1 mm, median OS was not reached and 30 months. At multivariate analysis, R1 resection was found to be a significant prognostic factor independent of clearance definition only in the case of the adoption of LEEPP. Conclusions. The 1 mm clearance is the most effective factor in determining the R1 rate after PD. However, the pathological method is crucial to accurately evaluate its prognostic role: only R1 resections obtained with the adoption of LEEPP seem to significantly affect prognosis. MDPI 2021-04-26 /pmc/articles/PMC8123600/ /pubmed/33926138 http://dx.doi.org/10.3390/cancers13092097 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nappo, Gennaro
Borzomati, Domenico
Zerbi, Alessandro
Spaggiari, Paola
Boggi, Ugo
Campani, Daniela
Mrowiec, Sławomir
Liszka, Łukasz
Coppola, Alessandro
Amato, Michela
Petitti, Tommasangelo
Vistoli, Fabio
Montorsi, Marco
Perrone, Giuseppe
Coppola, Roberto
Caputo, Damiano
The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial
title The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial
title_full The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial
title_fullStr The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial
title_full_unstemmed The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial
title_short The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial
title_sort role of pathological method and clearance definition for the evaluation of margin status after pancreatoduodenectomy for periampullary cancer. results of a multicenter prospective randomized trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123600/
https://www.ncbi.nlm.nih.gov/pubmed/33926138
http://dx.doi.org/10.3390/cancers13092097
work_keys_str_mv AT nappogennaro theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT borzomatidomenico theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT zerbialessandro theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT spaggiaripaola theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT boggiugo theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT campanidaniela theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT mrowiecsławomir theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT liszkałukasz theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT coppolaalessandro theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT amatomichela theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT petittitommasangelo theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT vistolifabio theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT montorsimarco theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT perronegiuseppe theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT coppolaroberto theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT caputodamiano theroleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT nappogennaro roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT borzomatidomenico roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT zerbialessandro roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT spaggiaripaola roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT boggiugo roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT campanidaniela roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT mrowiecsławomir roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT liszkałukasz roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT coppolaalessandro roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT amatomichela roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT petittitommasangelo roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT vistolifabio roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT montorsimarco roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT perronegiuseppe roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT coppolaroberto roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial
AT caputodamiano roleofpathologicalmethodandclearancedefinitionfortheevaluationofmarginstatusafterpancreatoduodenectomyforperiampullarycancerresultsofamulticenterprospectiverandomizedtrial